Suppr超能文献

[转移性乳腺癌犬的弥散性血管内凝血与高纤维蛋白溶解]

[Disseminated intravascular coagulation and hyperfibrinolysis in dogs with metastasizing mammary carcinoma].

作者信息

Mischke R, Wohlsein P, Busse L, Pohlenz J

机构信息

Klinik für kleine Haustiere, Tierärztlichen Hochschule Hannover.

出版信息

Schweiz Arch Tierheilkd. 1998;140(12):497-505.

PMID:9863356
Abstract

The alterations of the haemostatic system (platelet count, activated partial thromboplastin time [APTT], thromboplastin time [standard test, modified test], thrombin time, fibrinogen concentration, activity of the coagulation factors II, V, VII, X, VIII:C, IX, XI, XII, of prekallikrein, high molecular weight kininogen, antithrombin III, protein C, plasminogen and alpha 2-plasmin inhibitor, concentration of soluble fibrin and fibrin(ogen) degradation products [FDP], resonance thrombogram) were described in seven dogs with haemorrhagic diathesis in consequence of an infiltrative, growing mammary carcinoma with multifocal invasion of lymphatic and blood vessels. In most of the cases metastases in different organs could be demonstrated. In every case a serious stage of disseminated intravascular coagulation and hyperfibrinolysis was existent. This was indicated by the distinctly increased concentration (p < 0.0001) of soluble fibrin (27.7 [16.0-79.2] micrograms/ml, median [minimum-maximum], reference range [RR.]: < 9.4 micrograms/ml) and FDP (340 [50-860] micrograms/ml, RR.: < 18 micrograms/ml) as well as a diminished plasma level of nearly all components of the coagulation and fibrinolytic system concerning especially the concentration of fibrinogen (0.16 [0.01-0.46] g/l, RR.: 1.17-3.09 g/l), the activity of factors V (30 [21-40]%, RR.: 75-158%) and VIII:C (9 [4-16]%, RR.: 72-136%) as well as the activity of protein C (8 [3-13]%, RR.: 68-139%) (each: p < 0.0001).

摘要

对7只因浸润性生长的乳腺癌伴多灶性淋巴管和血管侵犯而导致出血素质的犬的止血系统改变(血小板计数、活化部分凝血活酶时间[APTT]、凝血酶原时间[标准试验、改良试验]、凝血酶时间、纤维蛋白原浓度、凝血因子II、V、VII、X、VIII:C、IX、XI、XII、前激肽释放酶、高分子量激肽原、抗凝血酶III、蛋白C、纤溶酶原和α2 -纤溶酶抑制剂的活性、可溶性纤维蛋白和纤维蛋白(原)降解产物[FDP]的浓度、旋转血栓弹力图)进行了描述。在大多数病例中,可证实不同器官有转移。在每个病例中,均存在弥散性血管内凝血和高纤维蛋白溶解的严重阶段。这表现为可溶性纤维蛋白(27.7[16.0 - 79.2]微克/毫升,中位数[最小值 - 最大值],参考范围[RR.]:<9.4微克/毫升)和FDP(340[50 - 860]微克/毫升,RR.:<18微克/毫升)浓度显著升高(p <0.0001),以及凝血和纤维蛋白溶解系统几乎所有成分的血浆水平降低,尤其是纤维蛋白原浓度(0.16[0.01 - 0.46]克/升,RR.:1.17 - 3.09克/升)、因子V活性(30[21 - 40]%,RR.:75 - 158%)和VIII:C活性(9[4 - 16]%,RR.:72 - 136%)以及蛋白C活性(8[3 - 13]%,RR.:68 - 139%)(均为:p <0.0001)。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验